VR Logo

Caplin Point Laboratories Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1990

Chairman: C C Paarthipan

Managing Director: Sridhar Ganesan

Group: --

Listing: NSE: CAPLIPOINT, BSE: 524742

Headquarters: Chennai, Tamil Nadu

Website: www.caplinpoint.net

Key Facts

Market cap: R 2,418.68 Cr

Revenue (TTM): R 835.31 Cr

Earnings (TTM): R 216.08 Cr

Cash: R 222.61 Cr

Total Debt: R 0.54 Cr

Promoters' ownership: 69.03%

Liquidity: High

52 Week range: R 176.20 - 466.90

Face value: R2.00

Shares outstanding: 7,56,42,750

10 Years Aggregate:

  • CFO: 456.20 Cr
  • EBITDA: 759.70 Cr
  • Net Profit: 563.44 Cr

Stock Performance

Time Period Caplin Point Laboratories S&P BSE Healthcare S&P BSE Small Cap
YTD6.2316.51-20.49
1 month-11.572.05-1.88
3 months6.5316.07-20.54
1 Year-23.2817.60-26.73
3 Years-15.654.88-10.29
5 Years10.98-1.53-0.70
10 Years63.4311.042.45
As on 29-May-2020
Year Caplin Point Laboratories S&P BSE Small Cap S&P BSE Healthcare
2019-21.44-6.85-3.55
2018-39.09-23.41-5.89
201783.5259.640.49
201623.671.77-12.88
2015246.566.7615.06
2014364.6969.2447.43
201329.18-11.2322.55